Chris R Lively from Waunakee, WI, age 65

Resumes

Senior Director - Biotech Services

View page

Location:

Madison, WI

Industry:

Pharmaceuticals

Work:

Eag Laboratories
Senior Director - Biotech Services
Biotechnique Llc Apr 2016 - Dec 2016
Director of Manufacturing
Ppd Dec 2004 - Mar 2016
Director, Biopharmaceutical Services
Powderject Vaccines Feb 1998 - Nov 2004
Director of Formulations, Analytical Development and Stability Programs
Pharmacia Biotech Sep 1991 - Feb 1998
Director of Operations

Education:

University of Wisconsin - Milwaukee
Master of Science, Masters, Biochemistry University of Wisconsin - Milwaukee
Doctorates, Doctor of Philosophy, Biochemistry, Philosophy Indiana University Bloomington
Bachelors, Bachelor of Science, Chemistry

Skills:

Pharmaceutical Industry
Management
Biotechnology
Clinical Development
Clinical Trials
Cro
Ctms
Leadership
R&D
Analytical Chemistry
Pharmaceutics
Gcp
Operations Management

Chris Lively

View page

Chris Lively

View page

Publications

Wikipedia

Fate of Chris Lively and Wife

View page

Fate of Chris Lively and Wife is an American folk song by Blind Alfred Reed. It tells the story of a man and his wife who were killed when a train collided ...

Us Patents

Nucleic Acid Coated Particles Suitable For Temporary Storage

View page

US Patent:

8349364, Jan 8, 2013

Filed:

Sep 29, 2003

Appl. No.:

10/529010

Inventors:

Chris Robert Lively - Madison WI, US
Robert DeLong - Chapel Hill NC, US

Assignee:

Powderject Research Limited - Oxford

International Classification:

A61K 9/14
A61K 9/16
A61K 9/50
C12N 15/87
C12N 15/11
A61K 48/00

US Classification:

424489, 435459, 977704, 977722, 514 44 R, 514 44 A

Abstract:

Particles are provided which are suitable for delivery from a particle-mediated delivery device. The particles are obtained by precipitating a nucleic acid on inert metal carrier particles in the presence of a nucleic acid condensing agent and a metal ion chelating agent. Also described are processes for preparing the particles, and therapeutic methods using the particles including methods of nucleic acid immunization and gene therapy.

Room Temperature Stable Reagent Semi-Spheres

View page

US Patent:

55653189, Oct 15, 1996

Filed:

Sep 2, 1994

Appl. No.:

8/300015

Inventors:

David W. Walker - Milwaukee WI
Robert A. DiFrancesco - Hales Corners WI
Jean A. Heaster - Brookfield WI
James F. Jolly - Glendale WI
Chris R. Lively - Glendale WI
Suzanne B. Treml - Milwaukee WI

Assignee:

Pharmacia Biotech, Inc. - Milwaukee WI

International Classification:

C12Q 100
C12Q 137
G01N 3353

US Classification:

435 4

Abstract:

A reagent semi-sphere is disclosed comprising at least one biological reagent and a glass forming filler material in a concentration sufficient to facilitate formation of a glassy, porous composition, wherein the reagent semi-sphere is room temperature stable, water soluble, and has a T. sub. g above room temperature. A method is provided for making the reagent semi-sphere comprising providing an aqueous solution of a buffered biological reagent; mixing a glass forming filler material with the buffered reagent solution to form an emulsion wherein the concentration of the filler material is sufficient to facilitate formation of a glassy, porous composition having a predetermined semi-spherical shape; dispensing the emulsion in the form of substantially uniform droplets; collecting the droplets on an inert medium to form semi-spheres; and vacuum drying the droplets, under conditions suitable for maintaining the predetermined semi-spherical shape, to form the reagent semi-sphere; wherein the reagent semi-sphere is room temperature stable, water soluble, and has a T. sub. g above room temperature.

Videos & Images